Literature DB >> 11908703

Inhibitory effects of incomplete Freund's adjuvant on experimental autoimmune encephalomyelitis.

Alex Zamora1, Agata Matejuk, Marc Silverman, Arthur A Vandenbark, Halina Offner.   

Abstract

Freund's incomplete adjuvant (IFA), an aqueous/oil emulsion that is widely used in combination with antigenic proteins and peptides to induce tolerance, is considered to be immunologically inert. However, sporadic reports indicate that IFA may itself have inhibitory properties on induction of adjuvant induced arthritis and spontaneous diabetes. In the current study, the effects of IFA/saline were evaluated on the induction of experimental autoimmune encephalomyelitis (EAE) in three different strains of mice. IFA/saline given i.p. in two doses of > 100 microl 10 days apart were found to inhibit EAE induction to varying degrees in all three strains of mice in a dose dependent fashion. The IFA/saline injections inhibited both mitogen and antigen-induced T cell proliferation, induced elevated secretion of IFN-gamma and IL-10 by neuroantigen specific T cells, and reduced expression of cytokines, chemokines, and chemokine receptors of CNS-infiltrating mononuclear cells. These data demonstrate for the first time a direct inhibitory effect of IFA/saline on EAE, and re-emphasize the need to properly control experiments using IFA to induce antigen-specific tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11908703     DOI: 10.1080/08916930290005873

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  6 in total

1.  Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.

Authors:  Luis M Vence; Chiyu Wang; Himabindu Pappu; Ryan E Anson; Tejal A Patel; Priscilla Miller; Roland Bassett; Gregory Lizee; Willem W Overwijk; Krishna Komanduri; Cara Benjamin; Gladys Alvarado; Sapna P Patel; Kevin Kim; Nicholas E Papadopoulos; Agop Y Bedikian; Jade Homsi; Wen-Jen Hwu; Richard Boyd; Laszlo Radvanyi; Patrick Hwu
Journal:  J Immunother       Date:  2013-05       Impact factor: 4.456

2.  In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.

Authors:  Divya Sagar; Shet Masih; Todd Schell; Steven Jacobson; Joseph D Comber; Ramila Philip; Brian Wigdahl; Pooja Jain; Zafar K Khan
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

3.  Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis.

Authors:  Laura Northrup; J Daniel Griffin; Matthew A Christopher; Lorena R Antunez; Brittany L Hartwell; Chad J Pickens; Cory Berkland
Journal:  J Control Release       Date:  2017-09-28       Impact factor: 9.776

4.  Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.

Authors:  S Stosic-Grujicic; Z Ramic; V Bumbasirevic; L Harhaji; M Mostarica-Stojkovic
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 5.  Tolerogenic vaccines for the treatment of cardiovascular diseases.

Authors:  Fernando Lozano Vigario; Johan Kuiper; Bram Slütter
Journal:  EBioMedicine       Date:  2020-06-20       Impact factor: 8.143

6.  Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration.

Authors:  Rachel E James; Renee Schalks; Eleanor Browne; Ioanna Eleftheriadou; Carmen Picon Munoz; Nicholas D Mazarakis; Richard Reynolds
Journal:  Acta Neuropathol Commun       Date:  2020-05-12       Impact factor: 7.801

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.